Literature DB >> 12620175

Diagnosing skin malignancy: assessment of predictive clinical criteria and risk factors.

Scott M Strayer1, Peter L Reynolds.   

Abstract

Expect to encounter 6 to 7 cases of basal cell cancer, 1 to 2 cases of squamous cell cancer, and approximately 1 case of melanoma every year. There is good evidence for using the American Cancer Society's ABCDE criteria as a clinical diagnostic test to rule out malignant melanoma). The revised 7-point checklist has high sensitivity and is therefore useful for ruling out a diagnosis of malignant melanoma. However, its low specificity yields many false-positive results. The gold standard for diagnosis of skin malignancies is a tissue biopsy. If any doubt exists about the diagnosis, a biopsy should be performed.

Entities:  

Mesh:

Year:  2003        PMID: 12620175

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  4 in total

1.  Clinical guidelines for the recognition of melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker; Katharine M Acland; Richard J Turner; Jonathan Bowling
Journal:  J Foot Ankle Res       Date:  2010-11-01       Impact factor: 2.303

2.  Vismodegib (erivedge) for advanced Basal cell carcinoma.

Authors:  Chris Fellner
Journal:  P T       Date:  2012-12

3.  [Changes in treatment of squamous cell carcinoma over time. A process analysis].

Authors:  C Rogalski; G Gelbrich; R Renner; K Hebestreit; U Paasch
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

4.  Comparison of computer systems and ranking criteria for automatic melanoma detection in dermoscopic images.

Authors:  Kajsa Møllersen; Maciel Zortea; Thomas R Schopf; Herbert Kirchesch; Fred Godtliebsen
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.